insights_auto
Outlook: 21.2% bullish·42.4% bearish
Go to analysischevron_right
XENE:NASDAQ
Xenon Pharmaceuticals Inc
39,75 USD
arrow_downward
-30,69%(-17,60) 1D
39,80 USD
arrow_upward
+0,13% (+0,050)bedtimeAfter hours
Closed: 18-сен., 16:00:00 GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for XENE...
Open
44,02 USD
High
44,85 USD
Low
39,08 USD
Mkt. cap
3,85 млд
Avg. vol.
676,14 миң
Volume
17,95 млн
52-wk high
72,66 USD
52-wk low
35,97 USD
EPS
-4,74 USD
Beta
0,61
Shares outstanding
96,84 млн
No. of employees
364
Open
44,02 USD
High
44,85 USD
Low
39,08 USD
Mkt. cap
3,85 млд
Avg. vol.
676,14 миң
Volume
17,95 млн
52-wk high
72,66 USD
52-wk low
35,97 USD
EPS
-4,74 USD
Beta
0,61
Shares outstanding
96,84 млн
No. of employees
364
News stories
From web sources and news partners
Yahoo Finance
·
11 саат мурун
Why Xenon Pharmaceuticals (XENE) Is Down 32.2% After Pausing Psychiatry Trials Despite Positive NDA Data
Investor's Business Daily
·
1 күн мурун
Why This Biotech Just Erased Its One-Day 50% Pop
Barchart.com
·
1 күн мурун
XENE Stock Plummets as Xenon Pharmaceuticals Pauses Drug Trial
About Xenon Pharmaceuticals Inc
CEO-
Employees364
Founded1996
HeadquartersВанкувер, Бритиш Колумбия, Канада
Sector-
Websitexenon-pharma.com